Citadel Advisors’s Conformis, Inc. Common Stock CFMS Stock Holding History

Citadel Advisors’s Portfolio CFMS Stock Details CFMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,097	Closed	-$36K	–	14126
2022 Q2	$36K	Buy	4,097 +2,922	+249%	+$33.4K	﹤0.01%	12134
2022 Q1	$18K	Sell	1,175 -9,739	-89%	-$160K	﹤0.01%	13282
2021 Q4	$208K	Buy	10,914 +9,349	+597%	+$240K	﹤0.01%	11772
2021 Q3	$52K	Buy	+1,565	New	+$55.2K	﹤0.01%	13359
2021 Q2	–	Sell	-2,941	Closed	-$73K	–	14755
2021 Q1	$73K	Buy	+2,941	New	+$79.3K	﹤0.01%	12712
2020 Q2	–	Sell	-3,114	Closed	-$49K	–	10745
2020 Q1	$49K	Buy	+3,114	New	+$76.1K	﹤0.01%	9041
2018 Q3	–	Sell	-468	Closed	-$14K	–	9874
2018 Q2	$14K	Buy	+468	New	+$16.2K	﹤0.01%	8703
2018 Q1	–	Sell	-664	Closed	-$40K	–	8971
2017 Q4	$40K	Sell	664 -3,895	-85%	-$311K	﹤0.01%	7695
2017 Q3	$401K	Buy	4,559 +3,086	+210%	+$306K	﹤0.01%	5633
2017 Q2	$158K	Buy	+1,473	New	+$177K	﹤0.01%	6709
2017 Q1	–	Sell	-1,807	Closed	-$366K	–	8217
2016 Q4	$366K	Buy	+1,807	New	+$400K	﹤0.01%	5391

Other funds holding CFMS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AWE

Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return

Citadel Advisors's CFMS Position: Q3 2022 in Review

Citadel Advisors sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2022, closing a stake of 4,097 shares — an estimated $36K sold.

Citadel Advisors first reported a position in CFMS in Q4 2016 and held it in 11 quarters. The position peaked at $401K in Q3 2017. 69 funds tracked by Wall St. Rank hold CFMS as of Q3 2022.

Citadel Advisors reported no remaining Conformis, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 4,097 Conformis, Inc. Common Stock shares in Q3 2022, an estimated $36K.
Citadel Advisors first reported a position in Conformis, Inc. Common Stock in Q4 2016 and held it in 11 quarters.
Citadel Advisors's Conformis, Inc. Common Stock position peaked at $401K in Q3 2017.
69 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.